{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:58:24Z","timestamp":1783465104994,"version":"3.55.0"},"reference-count":49,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Hepatitis C Virus (HCV) remains a global health challenge as WHO elimination targets are not achievable in most countries, mainly due to the high number of undiagnosed individuals. In Italy, where national elimination efforts are ongoing, regional disparities further hinder progress. This study aimed to characterize the hidden burden of chronic HCV infection across t he territory of the Province of Salerno, Southern Italy, to suggest a novel municipal-level screening approach, with implications for national strategies. Methods: We analyzed records of residents diagnosed with chronic HCV infection and linked to care between 2015 and 2022. Data included age, sex, municipality of residence, HCV genotype, and fibrosis stage. Observed prevalence was compared with expected prevalence derived from national\/regional benchmarks. Municipalities were categorized as urban or rural based on the resident population. Results: A total of 3528 cases were identified across 139 municipalities. Patients had a mean age of 63 years, and 54% were male. Half were diagnosed at an advanced stage (F3\u2013F4), with genotype 1b being predominant. The hidden burden increased with age and showed a higher prevalence in rural areas compared to urban ones, with values of about 7 vs. 3 per 1000 inhabitants respectively. Logistic regression analysis identified age, male sex, urban residence, and genotype 1b as factors associated with advanced fibrosis or cirrhosis. Conclusions: This is the first Italian study to apply a standardized municipal-level classification to quantify the hidden burden of HCV. The model identifies underdiagnosed areas, highlights urban\u2013rural disparities (a higher degree of underdiagnosis in rural areas versus a higher frequency of late diagnosis in urban ones), and provides a replicable tool for precision public health. Its adoption could enhance national HCV elimination efforts by supporting targeted screening, optimized resource allocation, and equitable access to care.<\/jats:p>","DOI":"10.3390\/v17101392","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:18:54Z","timestamp":1760948334000},"page":"1392","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Novel Municipal-Level Approach to Uncover the Hidden Burden of Hepatitis C: A Replicable Model for National Elimination Strategies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8245-5305","authenticated-orcid":false,"given":"Pietro","family":"Torre","sequence":"first","affiliation":[{"name":"Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-6151","authenticated-orcid":false,"given":"Silvana Mirella","family":"Aliberti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, 84081 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Sarcina","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4551-2589","authenticated-orcid":false,"given":"Mariano","family":"Festa","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"D\u2019Amore","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u2019Adamo","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Umberto I Hospital, Nocera Inferiore, 84014 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gambardella","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, San Luca Hospital, Vallo della Lucania, 84078 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9094-765X","authenticated-orcid":false,"given":"Antonella","family":"Santonicola","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Manzi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-8201","authenticated-orcid":false,"given":"Mario","family":"Masarone","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Capunzo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, 84081 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6498","authenticated-orcid":false,"given":"Marcello","family":"Persico","sequence":"additional","affiliation":[{"name":"Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,19]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024, August 29). Hepatitis C-Fact Sheets. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Torre, P., Festa, M., Sarcina, T., Masarone, M., and Persico, M. (2024). Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years. Viruses, 16.","DOI":"10.3390\/v16111792"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study","volume":"7","author":"Blach","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2468-1253(23)00408-9","article-title":"WHO hepatitis C elimination targets: The global equity challenge","volume":"9","author":"Heath","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","unstructured":"WHO (2016). Global health sector strategy on viral hepatitis 2016\u20132021, Towards Ending Viral Hepatitis."},{"key":"ref_6","first-page":"100792","article-title":"Prevalence of chronic HCV infection in EU\/EEA countries in 2019 using multiparameter evidence synthesis","volume":"36","author":"Thomadakis","year":"2024","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"ref_7","unstructured":"The CDA Foundation (2025, September 19). Hepatitis C. Available online: https:\/\/cdafound.org\/polaris\/elimination-maps\/."},{"key":"ref_8","unstructured":"(2023, May 12). Ridefinizione dei Criteri di Trattamento Per la Terapia Dell\u2019Epatite C Cronica, Available online: https:\/\/www.aifa.gov.it\/sites\/default\/files\/Determina_n._500-2017_Epatite-C.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.dld.2021.03.026","article-title":"Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation","volume":"54","author":"Kondili","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Torre, P., Coppola, R., Masarone, M., and Persico, M. (2023). Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience. Viruses, 15.","DOI":"10.3390\/v15112199"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100442","DOI":"10.1016\/j.epidem.2021.100442","article-title":"Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression","volume":"34","author":"Kondili","year":"2021","journal-title":"Epidemics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.3748\/wjg.v27.i28.4603","article-title":"Viral hepatitis: Milestones, unresolved issues, and future goals","volume":"27","author":"Torre","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination\u2013A path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers","volume":"364","author":"Arora","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.socscimed.2012.02.046","article-title":"Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?","volume":"75","author":"Flowerdew","year":"2012","journal-title":"Soc. Sci. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2011.02706.x","article-title":"Barriers to hepatitis C treatment","volume":"32","author":"McGowan","year":"2012","journal-title":"Liver Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2468-1253(23)00335-7","article-title":"Direct-acting antiviral therapies for hepatitis C infection: Global registration, reimbursement, and restrictions","volume":"9","author":"Marshall","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jmv.24635","article-title":"Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades","volume":"89","author":"Morisco","year":"2017","journal-title":"J. Med. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series (\u2606)","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_22","unstructured":"ISTAT (2025, April 01). Popolazione e Famiglie, Available online: https:\/\/esploradati.istat.it\/databrowser\/."},{"key":"ref_23","unstructured":"(2025, April 01). ISTAT. Available online: https:\/\/www.istat.it\/it\/files\/2023\/03\/Dinamica-demografica2022.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2105\/AJPH.2020.306149","article-title":"The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018","volume":"111","author":"Holtzman","year":"2021","journal-title":"Am. J. Public Health"},{"key":"ref_25","first-page":"249","article-title":"Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: A mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021","volume":"45","author":"Kondili","year":"2022","journal-title":"New Microbiol."},{"key":"ref_26","unstructured":"EUROSTAT (2025, April 01). Territorial Typologies Manual\u2013Degree of Urbanization, Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Territorial_typologies_manual_-_degree_of_urbanisation."},{"key":"ref_27","unstructured":"ISTAT (2025, April 01). Territorio, Available online: https:\/\/www.istat.it\/storage\/ASI\/2024\/capitoli\/C01.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nevola, R., Messina, V., Marrone, A., Coppola, N., Rescigno, C., Esposito, V., Sangiovanni, V., Claar, E., Pisaturo, M., and Fusco, F.M. (2022). Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic-Standardized National Screening or One Tailored to Local Epidemiology?. Biology, 11.","DOI":"10.3390\/biology11040609"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/liv.15273","article-title":"Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno","volume":"42","author":"Torre","year":"2022","journal-title":"Liver Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvh.13623","article-title":"Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: A cohort study","volume":"29","author":"Coppola","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14745\/ccdr.v44i78a02","article-title":"Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review","volume":"44","author":"Ha","year":"2018","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1010932832190","article-title":"High prevalence of HCV infection among the general population in a rural area of central Italy","volume":"17","author":"Raffaele","year":"2001","journal-title":"Eur. J. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101474","DOI":"10.1016\/j.jhepr.2025.101474","article-title":"Missed opportunities in HCV care: Trends in late diagnosis and treatment","volume":"7","author":"Tillakeratne","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2018.02.015","article-title":"Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas","volume":"53","author":"Andriulli","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gardini, I., Bartoli, M., Conforti, M., Mennini, F.S., and Marcellusi, A. (2019). Estimation of the number of HCV-positive patients in Italy. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223668"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Aliberti, S.M., and Capunzo, M. (2025). The Power of Environment: A Comprehensive Review of the Exposome\u2019s Role in Healthy Aging, Longevity, and Preventive Medicine-Lessons from Blue Zones and Cilento. Nutrients, 17.","DOI":"10.3390\/nu17040722"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Aliberti, S.M., Donato, A., Funk, R.H.W., and Capunzo, M. (2024). A Narrative Review Exploring the Similarities between Cilento and the Already Defined \u201cBlue Zones\u201d in Terms of Environment, Nutrition, and Lifestyle: Can Cilento Be Considered an Undefined \u201cBlue Zone\u201d?. Nutrients, 16.","DOI":"10.3390\/nu16050729"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Aliberti, S.M., De Caro, F., Funk, R.H.W., Schiavo, L., Gonnella, J., Boccia, G., and Capunzo, M. (2022). Extreme Longevity: Analysis of the Direct or Indirect Influence of Environmental Factors on Old, Nonagenarians, and Centenarians in Cilento, Italy. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031589"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","article-title":"The exposome and liver disease-how environmental factors affect liver health","volume":"79","author":"Barouki","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_40","first-page":"305","article-title":"Hepatitis C virus infection and nonalcoholic steatohepatitis","volume":"8","author":"Patel","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., and Pinto, A. (2019). Metabolic and Vascular Effect of the Mediterranean Diet. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194716"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ejcn.2017.91","article-title":"The mystery of longevity in Cilento: A mix of a good dose of genetic predisposition and a balanced diet based on the Mediterranean model","volume":"71","author":"Bifulco","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/liv.15727","article-title":"A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969\u20131989 birth-cohort","volume":"43","author":"Piccinelli","year":"2023","journal-title":"Liver Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/liv.15314","article-title":"Screening for hepatitis C at the time of the pandemic: Need to adjust the shot","volume":"42","author":"Torre","year":"2022","journal-title":"Liver Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/liv.15216","article-title":"Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination","volume":"42","author":"Rizzardini","year":"2022","journal-title":"Liver Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1093\/infdis\/jiad038","article-title":"From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy","volume":"228","author":"Kondili","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_47","unstructured":"(2023, July 04). HCV: Eradicazione del Virus Sul Territorio Nazionale. Available online: https:\/\/www.epac.it\/cm-files\/2019\/10\/03\/position-paper-hcv-def.pdf."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and Treatment Program to Eliminate Hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.23802","article-title":"Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care","volume":"52","author":"Arora","year":"2010","journal-title":"Hepatology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1392\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:30:07Z","timestamp":1760949007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["v17101392"],"URL":"https:\/\/doi.org\/10.3390\/v17101392","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,19]]}}}